Sunil Healthcare Ltd

Sunil Healthcare Limited will hold a board meeting on November 13, 2026, to consider and approve the unaudited financial results for both standalone and consolidated entities for the second quarter and first half year ended September 30, 2026, of the financial year 2026-27. Trading window for the company will remain closed from October 1, 2026, to November 15, 2026, as previously intimated on September 25, 2026.

Sunil Healthcare Ltd announced a revision of its credit ratings following an assessment by Brickwork Ratings India Pvt. Ltd. (“Brickwork Ratings”), who assigned a Long Term Bank Facilities rating of BWRBBB-, Outlook Stable, and a Short Term Bank Facilities rating of BWR A3, both of which represent upgrades from previous ratings; previously, Care Ratings Limited had assigned Long Term Bank Facilities a rating of CARE BB+, Outlook Stable, and Short Term Bank Facilities a rating of CARE A4+. The Brickwork Ratings letter, reference number BWR/BLR/DEL/SRC/Shyam Sunder Narang/4416/2026-27, was dated October 01, 2026, and the ratings are effective from October 03, 2026, superseding the ratings previously provided by Care Ratings Limited for Long Term Bank Facilities and Short Term Bank Facilities.

Sunil Healthcare Ltd. informed the Bombay Stock Exchange Limited and The Calcutta Stock Exchange Ltd. that the trading window for dealing in the company's securities will be closed for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the second quarter/half year of financial year 2026-27 ended on September 30, 2026.

SunilHealthcareLtd. informed the Bombay Stock Exchange and The Calcutta Stock Exchange that its register of members and share transfer book will remain closed from September 22, 2026, to September 28, 2026, for the company's 52nd Annual General Meeting to be held on September 28, 2026, via video conferencing, with the company's registered office in New Delhi deemed as the venue; the company has appointed MUFG Intime India Private Limited to facilitate remote e-voting and video conferencing, with the e-voting period running from September 25, 2026, at 9:00 a.m. to September 27, 2026, at 5:00 p.m.

Sunil Healthcare Ltd share price declined by 1.43% to Rs 70.78 after the company's net profit plunged by 69.74% to Rs 0.46 crore, while revenue from operations softened by 3.70% to Rs 18.99 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.19 lakh crore, gaining 4.61%. It has inched up 0.99% over last one week and advanced by 11.20% in last one month while the market capitalization of Sunil Healthcare Ltd has improved by 2.54% and 11.28% in the same period respectively. Profit before tax (PBT) of Sunil Healthcare Ltd stood at Rs 0.2 crore in Q2 FY26, crashing by 80.58% year-on-year, and tumbling by 121.05% quarter-on-quarter. EBITDA came in at Rs 3 crore, heading higher 11.57% YoY and expanding by 76.47% sequentially. Total expenses marginally dropped 9.22% to Rs 17.52 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 9.43 crore, jumping 61.75% YoY, while employee benefits expense was at Rs 3.17 crore, easing 1.60% YoY. For the TTM ended FY26, revenue from operations declined slightly by 7.51% to Rs 83.42 crore, while net profit witnessed a sharp fall of 20.67% to Rs 1.42 crore, compared to previous TTM. EBITDA tumbled by 187% to Rs 8.92 crore, and PBT collapsed by 52.34% to Rs 1.22 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 11.52 crore in FY26, as against Rs 15.4 crore in FY25. Sunil Healthcare Ltd retreated by 6.36% in last one year, significantly underperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.

Sunil Healthcare Ltd. will hold a meeting of its Board of Directors on August 13, 2026, through video conferencing/audio visual connection to consider and approve the unaudited financial results for the first quarter of fiscal year 2026-27 ended June 30, 2026, as stipulated by SEBI’s Listing Obligations and Disclosure Requirements Regulations, 2015; the trading window will remain closed from July 1, 2026, to August 15, 2026, inclusive.

Net profit of Sunil Healthcare rose 322.22% to Rs 1.52 crore in the quarter ended March 2026 as against Rs 0.36 crore during the previous quarter ended March 2025. Sales declined 6.98% to Rs 19.72 crore in the quarter ended March 2026 as against Rs 21.20 crore during the previous quarter ended March 2025. For the full year,net profit reported to Rs 4.01 crore in the year ended March 2026 as against net loss of Rs 1.42 crore during the previous year ended March 2025. Sales rose 5.15% to Rs 87.72 crore in the year ended March 2026 as against Rs 83.42 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales19.7221.20 -7 87.7283.42 5 OPM %9.8414.29 -14.5612.30 - PBDT0.691.96 -65 8.795.14 71 PBT-0.830.28 PL 2.35-1.22 LP NP1.520.36 322 4.01-1.42 LP Powered by Capital Market - Live

Sunil Healthcare will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net profit of Sunil Healthcare reported to Rs 0.59 crore in the quarter ended December 2025 as against net loss of Rs 0.54 crore during the previous quarter ended December 2024. Sales rose 6.74% to Rs 21.84 crore in the quarter ended December 2025 as against Rs 20.46 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales21.8420.46 7 OPM %16.5813.20 - PBDT2.461.34 84 PBT0.84-0.34 LP NP0.59-0.54 LP Powered by Capital Market - Live

Sunil Healthcare will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live